The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A Regulatory Role for p38δ MAPK in Keratinocyte Differentiation
Efimova, T., Broome, A., & Eckert, R. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302759200 · Cited by 135
RetractedMitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Rousseau, S., Houle, F., Landry, J., & Huot, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201380 · Cited by 845
MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., & Gaestel, M. (1999) · Nature Cell Biology · doi:10.1038/10061 · Cited by 763
Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)
Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J. A., Lin, S., & Han, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17920 · Cited by 746
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1
Yan, M., Dai, T., Deak, J. C., Kyriakis, J. M., Zon, L. I., Woodgett, J. R., & Templeton, D. J. (1994) · Nature · doi:10.1038/372798a0 · Cited by 705
Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J. C., Haegeman, G., Cohen, P., & Fiers, W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00542.x · Cited by 651
Enslen, H., Raingeaud, J., & Davis, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1741 · Cited by 539
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Self-citationGravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. R. (1998) · Europe PMC (PubMed Central) · Cited by 516
Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C., & Young, P. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6849 · Cited by 506
Jiang, Y., Gram, H., Zhao, M., New, L., Gu, J., Feng, L., Di Padova, F., Ulevitch, R. J., & Han, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30122 · Cited by 489
Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1
Kassel, O. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7108 · Cited by 479
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Self-citationDefective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3(Mkk3)-deficient mice
Lu, H.-T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1845 · Cited by 384
Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382
Cuenda, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.295 · Cited by 362
Read, M. A., Whitley, M. Z., Gupta, S., Pierce, J. W., Best, J., Davis, R. J., & Collins, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2753 · Cited by 345
Theodosiou, A., & Ashworth, A. (2002) · Genome biology · doi:10.1186/gb-2002-3-7-reviews3009 · Cited by 335
Zu, Y., Qi, J., Gilchrist, A., Fernandez, G. A., Vázquez‐Abad, D., Kreutzer, D. L., Huang, C. K., & Sha'afi, R. I. (1998) · PubMed · Cited by 330
Molecular Cloning and Characterization of a Novel p38 Mitogen-activated Protein Kinase
Wang, X. S., Diener, K., Manthey, C. L., Wang, S.-W., Rosenzweig, B., Bray, J., Delaney, J., Cole, C. N., Chan-Hui, P.-Y., Mantlo, N., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23668 · Cited by 330
ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation.
Lechner, C., Zahalka, M. A., Giot, J. F., Møller, N. P., & Ullrich, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4355 · Cited by 327
Liacini, A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00180-0 · Cited by 310
MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42
Fanger, G. R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4961 · Cited by 297
Juo, P., Kuo, C. J., Reynolds, S. E., Konz, R. F., Raingeaud, J., Davis, R. J., Biemann, H.-P., & Blenis, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.24 · Cited by 290
Li, X. (2002) · Endocrinology · doi:10.1210/en.143.8.3105 · Cited by 288
Zu, Y.-L., Qi, J., Gilchrist, A., Fernandez, G. A., Vazquez-Abad, D., Kreutzer, D. L., Huang, C.-K., & Sha’afi, R. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1982 · Cited by 283
Hale, K. K., Trollinger, D. B., Rihanek, M., & Manthey, C. L. (1999) · PubMed · Cited by 282
Nick, J. A., Avdi, N. J., Young, S. K., Lehman, L. A., McDonald, P. P., Frasch, S. C., Billstrom, M. A., Henson, P. M., Johnson, G. L., & Worthen, G. S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5257 · Cited by 281
Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein Kinase
Nemoto, S., Xiang, J., Huang, S., & Lin, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16415 · Cited by 280
Hale, K. K., Trollinger, D., Rihanek, M., & Manthey, C. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4246 · Cited by 245
Gerwins, P., Jonathan, L. B., & Johnson, G. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8288 · Cited by 242
Generation and Characterization of p38β (MAPK11) Gene-Targeted Mice
Beardmore, V. A., Hinton, H. J., Eftychi, C., Apostolaki, M., Armaka, M., Darragh, J., McIlrath, J., Carr, J. M., Armit, L. J., Clacher, C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.23.10454-10464.2005 · Cited by 236
Molecular Cloning of Mitogen-activated Protein/ERK Kinase Kinases (MEKK) 2 and 3
Blank, J. L., Gerwins, P., Elliott, E. M., Sather, S., & Johnson, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5361 · Cited by 230
The Stathmin/Tubulin Interaction in Vitro
Curmi, P. A., Andersen, S. S. L., Lachkar, S., Gavet, O., Karsenti, E., Knossow, M., & Sobel, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25029 · Cited by 226
Miyazawa, K., Mori, A., Miyata, H., Akahane, M., Ajisawa, Y., & Okudaira, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24832 · Cited by 224
Molecular determinants that mediate selective activation of p38 MAP kinase isoforms
Enslen, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1301 · Cited by 221
Reunanen, N., Li, S.-P., Ahonen, M., Foschi, M., Han, J., & Kähäri, V.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204296200 · Cited by 221
Hollander, A. P., Corke, K. P., Freemont, A. J., & Lewis, C. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1540::aid-art277>3.0.co;2-7 · Cited by 215
Badger, A. M., Griswold, D. E., Kapadia, R. D., Blake, S. M., Swift, B. A., Hoffman, S. J., Stroup, G. B., Webb, E. F., Rieman, D. J., Gowen, M., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<175::aid-anr22>3.0.co;2-s · Cited by 213
Pietersma, A., Tilly, B. C., Gaestel, M., de Jong, N., Lee, J. C., Koster, J. F., & Sluiter, W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.5886 · Cited by 212
Suzuki, M., Tetsuka, T., Yoshida, S., Watanabe, N., Kobayashi, M., Matsui, N., & Okamoto, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01717-2 · Cited by 198
Takekawa, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4973 · Cited by 193
Mechanisms of Disease: the link between RANKL and arthritic bone disease
Schett, G., Hayer, S., Zwerina, J., Redlich, K., & Smolen, J. S. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0036 · Cited by 191
Self-citationThe Role of TNFα and IL-1 in Rheumatoid Arthritis
Feldmann, M., Brennan, F. M., Foxwell, B. M. J., & Maini, R. M. (2000) · Current Directions in Autoimmunity · doi:10.1159/000060522 · Cited by 173
Regulation of gene expression by the small GTPase Rho through the ERK6 (p38γ) MAP kinase pathway
Marinissen, M. J., Chiariello, M., & Gutkind, J. S. (2001) · Genes & Development · doi:10.1101/gad.855801 · Cited by 167
A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKs
Tanoue, T., Yamamoto, T., Maeda, R., & Nishida, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101981200 · Cited by 165
Purification and Identification of a Major Activator for p38 from Osmotically Shocked Cells
Moriguchi, T., Toyoshima, F., Gotoh, Y., Iwamatsu, A., Irie, K., Mori, E., Kuroyanagi, N., Hagiwara, M., Matsumoto, K., & Nishida, E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26981 · Cited by 165
Nishikawa, M., Myoui, A., Tomita, T., Takahi, K., Nampei, A., & Yoshikawa, H. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11227 · Cited by 164
MAPKAP Kinase 2-Deficient Mice Are Resistant to Collagen-Induced Arthritis
Hegen, M., Gaestel, M., Nickerson‐Nutter, C. L., Lin, L., & Telliez, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1913 · Cited by 159
Stress-activated Protein Kinase-3 Interacts with the PDZ Domain of α1-Syntrophin
Hasegawa, M., Cuenda, A., Spillantini, M. G., Thomas, G. M., Buée-Scherrer, V., Cohen, P., & Goedert, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12626 · Cited by 158
Goebeler, M., Kilian, K., Gillitzer, R., Kunz, M., Yoshimura, T., Bröcker, E.-B., Rapp, U. R., & Ludwig, S. (1999) · Blood · doi:10.1182/blood.v93.3.857 · Cited by 158
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
Wadsworth, S. A., CAVENDER, D. E., Beers, S. A., Lalan, P., Schafer, P. H., Malloy, E. A., Wu, W., Fahmy, B., Olini, G. C., Davis, J. E., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35155-9 · Cited by 157
Signal transduction in rheumatoid arthritis
Sweeney, S. E., & Firestein, G. S. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00011 · Cited by 144
Self-citationChan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.415 · Cited by 141
Dual Leucine Zipper-bearing Kinase (DLK) Activates p46SAPK and p38 but Not ERK2
Fan, G., Merritt, S. E., Kortenjann, M., Shaw, P. E., & Holzman, L. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24788 · Cited by 140
Chan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · PubMed · Cited by 139
Korb, A., Tohidast-Akrad, M., Cetin, E., Axmann, R., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22080 · Cited by 138
Self-citationActivation of p38 MAPK is a key step in tumor necrosis factor–mediated inflammatory bone destruction
Zwerina, J., Hayer, S., Redlich, K., Bobacz, K., Kollias, G., Smolen, J. S., & Schett, G. A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21626 · Cited by 138
Self-citationKim, H. P., Wang, X., Zhang, J., Suh, G. Y., Benjamin, I. J., Ryter, S. W., & Choi, A. M. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2622 · Cited by 136
Pap, T., Aupperle, K. R., Gay, S., Firestein, G. S., & Gay, R. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<676::aid-anr117>3.0.co;2-6 · Cited by 116
Self-citationTanaka, N., Kamanaka, M., Enslen, H., Dong, C., Wysk, M., Davis, R. J., & Flavell, R. A. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf153 · Cited by 110
Inoue, T., Boyle, D. L., Corr, M., Hammaker, D. R., Davis, R. J., Flavell, R. A., & Firestein, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509188103 · Cited by 109
Self-citationRoles of tumor necrosis factor p55 and p75 receptors in TNF-α-induced vascular permeability
Ferrero, E., Zocchi, M. R., Magni, E., Panzeri, M. C., Curnis, F., Rugarli, C., Ferrero, M. E., & Corti, A. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.4.c1173 · Cited by 99
Mahlknecht, U., Will, J., Varin, A., Hoelzer, D. F., & Herbein, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3979 · Cited by 94
Sabio, G., REUVER, S., Feijóo, C. G., Hasegawa, M., Thomas, G. M., Centeno, F., Kuhlendahl, S., Leal‐Ortiz, S., Goedert, M., Garner, C. C., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031628 · Cited by 92
Hammaker, D. R., Boyle, D. L., Chabaud-Riou, M., & Firestein, G. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1612 · Cited by 86
Self-citationMatsumoto, M., SUDO, T., Maruyama, M., Osada, H., & Tsujimoto, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02231-6 · Cited by 83
Medicherla, S., Jing, Y., Mangadu, R., Jiang, Y., Zhao, J. J., Almirez, R. G., Kerr, I., Stebbins, E. G., O’Young, G., Kapoun, A. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098020 · Cited by 83
CD44 is a determinant of inflammatory bone loss
Hayer, S., Steiner, G. E., Görtz, B., Reiter, E., Tohidast-Akrad, M., Amling, M., Hoffmann, O., Redlich, K., Zwerina, J., Skriner, K., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040852 · Cited by 79
Self-citationPurification and Activation of Recombinant p38 Isoforms α, β, γ, and δ
Keesler, G. A., Bray, J., Hunt, J., Johnson, D. A., Gleason, T., Yao, Z., Wang, S., Parker, C. G., Yamane, H. K., Cole, C. N., et al. (1998) · Protein Expression and Purification · doi:10.1006/prep.1998.0947 · Cited by 76
p38 Mitogen-activated Protein Kinase Is Involved in Fas Ligand Expression
Hsu, S., Gavrilin, M. A., Tsai, M.-H., Han, J., & Lai, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25769 · Cited by 73
Toh, M., Yang, Y. H., Leech, M. T., Santos, L., & Morand, E. F. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20580 · Cited by 70
Görtz, B., Hayer, S., Tuerk, B., Zwerina, J., Smolen, J. S., & Schett, G. A. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1797 · Cited by 70
Self-citationChabaud-Riou, M., & Firestein, G. S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63108-2 · Cited by 65
Self-citationCong, F., & Goff, S. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13819 · Cited by 64
Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis
Révész, L., Blum, E., Padova, F. E. D., Buhl, T., Feifel, R., Gram, H., HIESTAND, P. C., Manning, U., & Rucklin, G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.106 · Cited by 60
Yamamoto, A., Fukuda, A., Seto, H., Miyazaki, T., Kadono, Y., Sawada, Y., Nakamura, I., Katagiri, H., Asano, T., Tanaka, Y., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11214 · Cited by 51
Cohen, D. (1997) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/s0300-9629(96)00266-6 · Cited by 49
Pratt, P. F., Bokemeyer, D., Foschi, M., Sorokin, A., & Dunn, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309256200 · Cited by 43
Roivainen, A. (1996) · British journal of rheumatology · doi:10.1093/rheumatology/35.10.933 · Cited by 39
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Self-citationBorst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis
Thwaites, R., Chamberlain, G., & Sacre, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00001 · Cited by 748
Yang, Y., Kim, S. C., Yu, T., Yi, Y.-S., Rhee, M. H., Sung, G.-H., Yoo, B. C., & Cho, J. Y. (2014) · Mediators of Inflammation · doi:10.1155/2014/352371 · Cited by 406
Post-transcriptional control of cytokine production
Anderson, P. (2008) · Nature Immunology · doi:10.1038/ni1584 · Cited by 376
Metadata
- Authors
- Schett, G., Zwerina, J., & Firestein, G.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 67
- Issue
- 7
- Pages
- 909-916
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2171784256
- Cited by
- 271
- References
- 88
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.